Global Protein Drugs Market Research Report 2024, Forecast to 2032
Report Overview
A type of drugs made of protein. These drugs usually have large molecular weight with proteincharacteristics.
The global Protein Drugs market size was estimated at USD 266900 million in 2023 and is projected to reach USD 503206.30 million by 2032, exhibiting a CAGR of 7.30% during the forecast period.
North America Protein Drugs market size was estimated at USD 78522.05 million in 2023, at a CAGR of 6.26% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Protein Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Protein Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Protein Drugs market in any manner.
Global Protein Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eli Lilly
Abbott Laboratories
UCB Group
Schering-Plough Corporation
Genentech
Johnson?Johnson
Bristol-Myers Squibb
Novo Nordisk
Biogen Idec
Dendreon Corporation
Amgen Inc.
Market Segmentation (by Type)
Antibody Drugs
Peptide Hormones
Blood Products
Enzymes
Market Segmentation (by Application)
Hospitals
Clinics
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Protein Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Protein Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
A type of drugs made of protein. These drugs usually have large molecular weight with proteincharacteristics.
The global Protein Drugs market size was estimated at USD 266900 million in 2023 and is projected to reach USD 503206.30 million by 2032, exhibiting a CAGR of 7.30% during the forecast period.
North America Protein Drugs market size was estimated at USD 78522.05 million in 2023, at a CAGR of 6.26% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Protein Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Protein Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Protein Drugs market in any manner.
Global Protein Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eli Lilly
Abbott Laboratories
UCB Group
Schering-Plough Corporation
Genentech
Johnson?Johnson
Bristol-Myers Squibb
Novo Nordisk
Biogen Idec
Dendreon Corporation
Amgen Inc.
Market Segmentation (by Type)
Antibody Drugs
Peptide Hormones
Blood Products
Enzymes
Market Segmentation (by Application)
Hospitals
Clinics
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Protein Drugs Market
- Overview of the regional outlook of the Protein Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Protein Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Protein Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Protein Drugs
1.2 Key Market Segments
1.2.1 Protein Drugs Segment by Type
1.2.2 Protein Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PROTEIN DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PROTEIN DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Protein Drugs Revenue Market Share by Company (2019-2024)
3.2 Protein Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Protein Drugs Market Size Sites, Area Served, Product Type
3.4 Protein Drugs Market Competitive Situation and Trends
3.4.1 Protein Drugs Market Concentration Rate
3.4.2 Global 5 and 10 Largest Protein Drugs Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 PROTEIN DRUGS VALUE CHAIN ANALYSIS
4.1 Protein Drugs Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PROTEIN DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 PROTEIN DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Protein Drugs Market Size Market Share by Type (2019-2024)
6.3 Global Protein Drugs Market Size Growth Rate by Type (2019-2024)
7 PROTEIN DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Protein Drugs Market Size (M USD) by Application (2019-2024)
7.3 Global Protein Drugs Market Size Growth Rate by Application (2019-2024)
8 PROTEIN DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Protein Drugs Market Size by Region
8.1.1 Global Protein Drugs Market Size by Region
8.1.2 Global Protein Drugs Market Size Market Share by Region
8.2 North America
8.2.1 North America Protein Drugs Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Protein Drugs Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Protein Drugs Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Protein Drugs Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Protein Drugs Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Eli Lilly
9.1.1 Eli Lilly Protein Drugs Basic Information
9.1.2 Eli Lilly Protein Drugs Product Overview
9.1.3 Eli Lilly Protein Drugs Product Market Performance
9.1.4 Eli Lilly Protein Drugs SWOT Analysis
9.1.5 Eli Lilly Business Overview
9.1.6 Eli Lilly Recent Developments
9.2 Abbott Laboratories
9.2.1 Abbott Laboratories Protein Drugs Basic Information
9.2.2 Abbott Laboratories Protein Drugs Product Overview
9.2.3 Abbott Laboratories Protein Drugs Product Market Performance
9.2.4 Abbott Laboratories Protein Drugs SWOT Analysis
9.2.5 Abbott Laboratories Business Overview
9.2.6 Abbott Laboratories Recent Developments
9.3 UCB Group
9.3.1 UCB Group Protein Drugs Basic Information
9.3.2 UCB Group Protein Drugs Product Overview
9.3.3 UCB Group Protein Drugs Product Market Performance
9.3.4 UCB Group Protein Drugs SWOT Analysis
9.3.5 UCB Group Business Overview
9.3.6 UCB Group Recent Developments
9.4 Schering-Plough Corporation
9.4.1 Schering-Plough Corporation Protein Drugs Basic Information
9.4.2 Schering-Plough Corporation Protein Drugs Product Overview
9.4.3 Schering-Plough Corporation Protein Drugs Product Market Performance
9.4.4 Schering-Plough Corporation Business Overview
9.4.5 Schering-Plough Corporation Recent Developments
9.5 Genentech
9.5.1 Genentech Protein Drugs Basic Information
9.5.2 Genentech Protein Drugs Product Overview
9.5.3 Genentech Protein Drugs Product Market Performance
9.5.4 Genentech Business Overview
9.5.5 Genentech Recent Developments
9.6 Johnson?Johnson
9.6.1 Johnson?Johnson Protein Drugs Basic Information
9.6.2 Johnson?Johnson Protein Drugs Product Overview
9.6.3 Johnson?Johnson Protein Drugs Product Market Performance
9.6.4 Johnson?Johnson Business Overview
9.6.5 Johnson?Johnson Recent Developments
9.7 Bristol-Myers Squibb
9.7.1 Bristol-Myers Squibb Protein Drugs Basic Information
9.7.2 Bristol-Myers Squibb Protein Drugs Product Overview
9.7.3 Bristol-Myers Squibb Protein Drugs Product Market Performance
9.7.4 Bristol-Myers Squibb Business Overview
9.7.5 Bristol-Myers Squibb Recent Developments
9.8 Novo Nordisk
9.8.1 Novo Nordisk Protein Drugs Basic Information
9.8.2 Novo Nordisk Protein Drugs Product Overview
9.8.3 Novo Nordisk Protein Drugs Product Market Performance
9.8.4 Novo Nordisk Business Overview
9.8.5 Novo Nordisk Recent Developments
9.9 Biogen Idec
9.9.1 Biogen Idec Protein Drugs Basic Information
9.9.2 Biogen Idec Protein Drugs Product Overview
9.9.3 Biogen Idec Protein Drugs Product Market Performance
9.9.4 Biogen Idec Business Overview
9.9.5 Biogen Idec Recent Developments
9.10 Dendreon Corporation
9.10.1 Dendreon Corporation Protein Drugs Basic Information
9.10.2 Dendreon Corporation Protein Drugs Product Overview
9.10.3 Dendreon Corporation Protein Drugs Product Market Performance
9.10.4 Dendreon Corporation Business Overview
9.10.5 Dendreon Corporation Recent Developments
9.11 Amgen Inc.
9.11.1 Amgen Inc. Protein Drugs Basic Information
9.11.2 Amgen Inc. Protein Drugs Product Overview
9.11.3 Amgen Inc. Protein Drugs Product Market Performance
9.11.4 Amgen Inc. Business Overview
9.11.5 Amgen Inc. Recent Developments
10 PROTEIN DRUGS REGIONAL MARKET FORECAST
10.1 Global Protein Drugs Market Size Forecast
10.2 Global Protein Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Protein Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Protein Drugs Market Size Forecast by Region
10.2.4 South America Protein Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Protein Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
11.1 Global Protein Drugs Market Forecast by Type (2025-2032)
11.2 Global Protein Drugs Market Forecast by Application (2025-2032)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Protein Drugs
1.2 Key Market Segments
1.2.1 Protein Drugs Segment by Type
1.2.2 Protein Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PROTEIN DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PROTEIN DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Protein Drugs Revenue Market Share by Company (2019-2024)
3.2 Protein Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Protein Drugs Market Size Sites, Area Served, Product Type
3.4 Protein Drugs Market Competitive Situation and Trends
3.4.1 Protein Drugs Market Concentration Rate
3.4.2 Global 5 and 10 Largest Protein Drugs Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 PROTEIN DRUGS VALUE CHAIN ANALYSIS
4.1 Protein Drugs Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PROTEIN DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 PROTEIN DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Protein Drugs Market Size Market Share by Type (2019-2024)
6.3 Global Protein Drugs Market Size Growth Rate by Type (2019-2024)
7 PROTEIN DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Protein Drugs Market Size (M USD) by Application (2019-2024)
7.3 Global Protein Drugs Market Size Growth Rate by Application (2019-2024)
8 PROTEIN DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Protein Drugs Market Size by Region
8.1.1 Global Protein Drugs Market Size by Region
8.1.2 Global Protein Drugs Market Size Market Share by Region
8.2 North America
8.2.1 North America Protein Drugs Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Protein Drugs Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Protein Drugs Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Protein Drugs Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Protein Drugs Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Eli Lilly
9.1.1 Eli Lilly Protein Drugs Basic Information
9.1.2 Eli Lilly Protein Drugs Product Overview
9.1.3 Eli Lilly Protein Drugs Product Market Performance
9.1.4 Eli Lilly Protein Drugs SWOT Analysis
9.1.5 Eli Lilly Business Overview
9.1.6 Eli Lilly Recent Developments
9.2 Abbott Laboratories
9.2.1 Abbott Laboratories Protein Drugs Basic Information
9.2.2 Abbott Laboratories Protein Drugs Product Overview
9.2.3 Abbott Laboratories Protein Drugs Product Market Performance
9.2.4 Abbott Laboratories Protein Drugs SWOT Analysis
9.2.5 Abbott Laboratories Business Overview
9.2.6 Abbott Laboratories Recent Developments
9.3 UCB Group
9.3.1 UCB Group Protein Drugs Basic Information
9.3.2 UCB Group Protein Drugs Product Overview
9.3.3 UCB Group Protein Drugs Product Market Performance
9.3.4 UCB Group Protein Drugs SWOT Analysis
9.3.5 UCB Group Business Overview
9.3.6 UCB Group Recent Developments
9.4 Schering-Plough Corporation
9.4.1 Schering-Plough Corporation Protein Drugs Basic Information
9.4.2 Schering-Plough Corporation Protein Drugs Product Overview
9.4.3 Schering-Plough Corporation Protein Drugs Product Market Performance
9.4.4 Schering-Plough Corporation Business Overview
9.4.5 Schering-Plough Corporation Recent Developments
9.5 Genentech
9.5.1 Genentech Protein Drugs Basic Information
9.5.2 Genentech Protein Drugs Product Overview
9.5.3 Genentech Protein Drugs Product Market Performance
9.5.4 Genentech Business Overview
9.5.5 Genentech Recent Developments
9.6 Johnson?Johnson
9.6.1 Johnson?Johnson Protein Drugs Basic Information
9.6.2 Johnson?Johnson Protein Drugs Product Overview
9.6.3 Johnson?Johnson Protein Drugs Product Market Performance
9.6.4 Johnson?Johnson Business Overview
9.6.5 Johnson?Johnson Recent Developments
9.7 Bristol-Myers Squibb
9.7.1 Bristol-Myers Squibb Protein Drugs Basic Information
9.7.2 Bristol-Myers Squibb Protein Drugs Product Overview
9.7.3 Bristol-Myers Squibb Protein Drugs Product Market Performance
9.7.4 Bristol-Myers Squibb Business Overview
9.7.5 Bristol-Myers Squibb Recent Developments
9.8 Novo Nordisk
9.8.1 Novo Nordisk Protein Drugs Basic Information
9.8.2 Novo Nordisk Protein Drugs Product Overview
9.8.3 Novo Nordisk Protein Drugs Product Market Performance
9.8.4 Novo Nordisk Business Overview
9.8.5 Novo Nordisk Recent Developments
9.9 Biogen Idec
9.9.1 Biogen Idec Protein Drugs Basic Information
9.9.2 Biogen Idec Protein Drugs Product Overview
9.9.3 Biogen Idec Protein Drugs Product Market Performance
9.9.4 Biogen Idec Business Overview
9.9.5 Biogen Idec Recent Developments
9.10 Dendreon Corporation
9.10.1 Dendreon Corporation Protein Drugs Basic Information
9.10.2 Dendreon Corporation Protein Drugs Product Overview
9.10.3 Dendreon Corporation Protein Drugs Product Market Performance
9.10.4 Dendreon Corporation Business Overview
9.10.5 Dendreon Corporation Recent Developments
9.11 Amgen Inc.
9.11.1 Amgen Inc. Protein Drugs Basic Information
9.11.2 Amgen Inc. Protein Drugs Product Overview
9.11.3 Amgen Inc. Protein Drugs Product Market Performance
9.11.4 Amgen Inc. Business Overview
9.11.5 Amgen Inc. Recent Developments
10 PROTEIN DRUGS REGIONAL MARKET FORECAST
10.1 Global Protein Drugs Market Size Forecast
10.2 Global Protein Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Protein Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Protein Drugs Market Size Forecast by Region
10.2.4 South America Protein Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Protein Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
11.1 Global Protein Drugs Market Forecast by Type (2025-2032)
11.2 Global Protein Drugs Market Forecast by Application (2025-2032)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Protein Drugs Market Size Comparison by Region (M USD)
Table 5. Global Protein Drugs Revenue (M USD) by Company (2019-2024)
Table 6. Global Protein Drugs Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Drugs as of 2022)
Table 8. Company Protein Drugs Market Size Sites and Area Served
Table 9. Company Protein Drugs Product Type
Table 10. Global Protein Drugs Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Protein Drugs
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Protein Drugs Market Challenges
Table 18. Global Protein Drugs Market Size by Type (M USD)
Table 19. Global Protein Drugs Market Size (M USD) by Type (2019-2024)
Table 20. Global Protein Drugs Market Size Share by Type (2019-2024)
Table 21. Global Protein Drugs Market Size Growth Rate by Type (2019-2024)
Table 22. Global Protein Drugs Market Size by Application
Table 23. Global Protein Drugs Market Size by Application (2019-2024) & (M USD)
Table 24. Global Protein Drugs Market Share by Application (2019-2024)
Table 25. Global Protein Drugs Market Size Growth Rate by Application (2019-2024)
Table 26. Global Protein Drugs Market Size by Region (2019-2024) & (M USD)
Table 27. Global Protein Drugs Market Size Market Share by Region (2019-2024)
Table 28. North America Protein Drugs Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Protein Drugs Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Protein Drugs Market Size by Region (2019-2024) & (M USD)
Table 31. South America Protein Drugs Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Protein Drugs Market Size by Region (2019-2024) & (M USD)
Table 33. Eli Lilly Protein Drugs Basic Information
Table 34. Eli Lilly Protein Drugs Product Overview
Table 35. Eli Lilly Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Eli Lilly Protein Drugs SWOT Analysis
Table 37. Eli Lilly Business Overview
Table 38. Eli Lilly Recent Developments
Table 39. Abbott Laboratories Protein Drugs Basic Information
Table 40. Abbott Laboratories Protein Drugs Product Overview
Table 41. Abbott Laboratories Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Abbott Laboratories Protein Drugs SWOT Analysis
Table 43. Abbott Laboratories Business Overview
Table 44. Abbott Laboratories Recent Developments
Table 45. UCB Group Protein Drugs Basic Information
Table 46. UCB Group Protein Drugs Product Overview
Table 47. UCB Group Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 48. UCB Group Protein Drugs SWOT Analysis
Table 49. UCB Group Business Overview
Table 50. UCB Group Recent Developments
Table 51. Schering-Plough Corporation Protein Drugs Basic Information
Table 52. Schering-Plough Corporation Protein Drugs Product Overview
Table 53. Schering-Plough Corporation Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Schering-Plough Corporation Business Overview
Table 55. Schering-Plough Corporation Recent Developments
Table 56. Genentech Protein Drugs Basic Information
Table 57. Genentech Protein Drugs Product Overview
Table 58. Genentech Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Genentech Business Overview
Table 60. Genentech Recent Developments
Table 61. Johnson?Johnson Protein Drugs Basic Information
Table 62. Johnson?Johnson Protein Drugs Product Overview
Table 63. Johnson?Johnson Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Johnson?Johnson Business Overview
Table 65. Johnson?Johnson Recent Developments
Table 66. Bristol-Myers Squibb Protein Drugs Basic Information
Table 67. Bristol-Myers Squibb Protein Drugs Product Overview
Table 68. Bristol-Myers Squibb Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Recent Developments
Table 71. Novo Nordisk Protein Drugs Basic Information
Table 72. Novo Nordisk Protein Drugs Product Overview
Table 73. Novo Nordisk Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Novo Nordisk Business Overview
Table 75. Novo Nordisk Recent Developments
Table 76. Biogen Idec Protein Drugs Basic Information
Table 77. Biogen Idec Protein Drugs Product Overview
Table 78. Biogen Idec Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Biogen Idec Business Overview
Table 80. Biogen Idec Recent Developments
Table 81. Dendreon Corporation Protein Drugs Basic Information
Table 82. Dendreon Corporation Protein Drugs Product Overview
Table 83. Dendreon Corporation Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Dendreon Corporation Business Overview
Table 85. Dendreon Corporation Recent Developments
Table 86. Amgen Inc. Protein Drugs Basic Information
Table 87. Amgen Inc. Protein Drugs Product Overview
Table 88. Amgen Inc. Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Amgen Inc. Business Overview
Table 90. Amgen Inc. Recent Developments
Table 91. Global Protein Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 92. North America Protein Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 93. Europe Protein Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 94. Asia Pacific Protein Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 95. South America Protein Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 96. Middle East and Africa Protein Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 97. Global Protein Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 98. Global Protein Drugs Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Protein Drugs Market Size Comparison by Region (M USD)
Table 5. Global Protein Drugs Revenue (M USD) by Company (2019-2024)
Table 6. Global Protein Drugs Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Drugs as of 2022)
Table 8. Company Protein Drugs Market Size Sites and Area Served
Table 9. Company Protein Drugs Product Type
Table 10. Global Protein Drugs Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Protein Drugs
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Protein Drugs Market Challenges
Table 18. Global Protein Drugs Market Size by Type (M USD)
Table 19. Global Protein Drugs Market Size (M USD) by Type (2019-2024)
Table 20. Global Protein Drugs Market Size Share by Type (2019-2024)
Table 21. Global Protein Drugs Market Size Growth Rate by Type (2019-2024)
Table 22. Global Protein Drugs Market Size by Application
Table 23. Global Protein Drugs Market Size by Application (2019-2024) & (M USD)
Table 24. Global Protein Drugs Market Share by Application (2019-2024)
Table 25. Global Protein Drugs Market Size Growth Rate by Application (2019-2024)
Table 26. Global Protein Drugs Market Size by Region (2019-2024) & (M USD)
Table 27. Global Protein Drugs Market Size Market Share by Region (2019-2024)
Table 28. North America Protein Drugs Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Protein Drugs Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Protein Drugs Market Size by Region (2019-2024) & (M USD)
Table 31. South America Protein Drugs Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Protein Drugs Market Size by Region (2019-2024) & (M USD)
Table 33. Eli Lilly Protein Drugs Basic Information
Table 34. Eli Lilly Protein Drugs Product Overview
Table 35. Eli Lilly Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Eli Lilly Protein Drugs SWOT Analysis
Table 37. Eli Lilly Business Overview
Table 38. Eli Lilly Recent Developments
Table 39. Abbott Laboratories Protein Drugs Basic Information
Table 40. Abbott Laboratories Protein Drugs Product Overview
Table 41. Abbott Laboratories Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Abbott Laboratories Protein Drugs SWOT Analysis
Table 43. Abbott Laboratories Business Overview
Table 44. Abbott Laboratories Recent Developments
Table 45. UCB Group Protein Drugs Basic Information
Table 46. UCB Group Protein Drugs Product Overview
Table 47. UCB Group Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 48. UCB Group Protein Drugs SWOT Analysis
Table 49. UCB Group Business Overview
Table 50. UCB Group Recent Developments
Table 51. Schering-Plough Corporation Protein Drugs Basic Information
Table 52. Schering-Plough Corporation Protein Drugs Product Overview
Table 53. Schering-Plough Corporation Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Schering-Plough Corporation Business Overview
Table 55. Schering-Plough Corporation Recent Developments
Table 56. Genentech Protein Drugs Basic Information
Table 57. Genentech Protein Drugs Product Overview
Table 58. Genentech Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Genentech Business Overview
Table 60. Genentech Recent Developments
Table 61. Johnson?Johnson Protein Drugs Basic Information
Table 62. Johnson?Johnson Protein Drugs Product Overview
Table 63. Johnson?Johnson Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Johnson?Johnson Business Overview
Table 65. Johnson?Johnson Recent Developments
Table 66. Bristol-Myers Squibb Protein Drugs Basic Information
Table 67. Bristol-Myers Squibb Protein Drugs Product Overview
Table 68. Bristol-Myers Squibb Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Recent Developments
Table 71. Novo Nordisk Protein Drugs Basic Information
Table 72. Novo Nordisk Protein Drugs Product Overview
Table 73. Novo Nordisk Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Novo Nordisk Business Overview
Table 75. Novo Nordisk Recent Developments
Table 76. Biogen Idec Protein Drugs Basic Information
Table 77. Biogen Idec Protein Drugs Product Overview
Table 78. Biogen Idec Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Biogen Idec Business Overview
Table 80. Biogen Idec Recent Developments
Table 81. Dendreon Corporation Protein Drugs Basic Information
Table 82. Dendreon Corporation Protein Drugs Product Overview
Table 83. Dendreon Corporation Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Dendreon Corporation Business Overview
Table 85. Dendreon Corporation Recent Developments
Table 86. Amgen Inc. Protein Drugs Basic Information
Table 87. Amgen Inc. Protein Drugs Product Overview
Table 88. Amgen Inc. Protein Drugs Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Amgen Inc. Business Overview
Table 90. Amgen Inc. Recent Developments
Table 91. Global Protein Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 92. North America Protein Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 93. Europe Protein Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 94. Asia Pacific Protein Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 95. South America Protein Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 96. Middle East and Africa Protein Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 97. Global Protein Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 98. Global Protein Drugs Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Industrial Chain of Protein Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Protein Drugs Market Size (M USD), 2019-2032
Figure 5. Global Protein Drugs Market Size (M USD) (2019-2032)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Protein Drugs Market Size by Country (M USD)
Figure 10. Global Protein Drugs Revenue Share by Company in 2023
Figure 11. Protein Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Protein Drugs Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Protein Drugs Market Share by Type
Figure 15. Market Size Share of Protein Drugs by Type (2019-2024)
Figure 16. Market Size Market Share of Protein Drugs by Type in 2022
Figure 17. Global Protein Drugs Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Protein Drugs Market Share by Application
Figure 20. Global Protein Drugs Market Share by Application (2019-2024)
Figure 21. Global Protein Drugs Market Share by Application in 2022
Figure 22. Global Protein Drugs Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Protein Drugs Market Size Market Share by Region (2019-2024)
Figure 24. North America Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Protein Drugs Market Size Market Share by Country in 2023
Figure 26. U.S. Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Protein Drugs Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Protein Drugs Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Protein Drugs Market Size Market Share by Country in 2023
Figure 31. Germany Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Protein Drugs Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Protein Drugs Market Size Market Share by Region in 2023
Figure 38. China Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Protein Drugs Market Size and Growth Rate (M USD)
Figure 44. South America Protein Drugs Market Size Market Share by Country in 2023
Figure 45. Brazil Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Protein Drugs Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Protein Drugs Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Protein Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 56. Global Protein Drugs Market Share Forecast by Type (2025-2032)
Figure 57. Global Protein Drugs Market Share Forecast by Application (2025-2032)
Figure 1. Industrial Chain of Protein Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Protein Drugs Market Size (M USD), 2019-2032
Figure 5. Global Protein Drugs Market Size (M USD) (2019-2032)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Protein Drugs Market Size by Country (M USD)
Figure 10. Global Protein Drugs Revenue Share by Company in 2023
Figure 11. Protein Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Protein Drugs Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Protein Drugs Market Share by Type
Figure 15. Market Size Share of Protein Drugs by Type (2019-2024)
Figure 16. Market Size Market Share of Protein Drugs by Type in 2022
Figure 17. Global Protein Drugs Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Protein Drugs Market Share by Application
Figure 20. Global Protein Drugs Market Share by Application (2019-2024)
Figure 21. Global Protein Drugs Market Share by Application in 2022
Figure 22. Global Protein Drugs Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Protein Drugs Market Size Market Share by Region (2019-2024)
Figure 24. North America Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Protein Drugs Market Size Market Share by Country in 2023
Figure 26. U.S. Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Protein Drugs Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Protein Drugs Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Protein Drugs Market Size Market Share by Country in 2023
Figure 31. Germany Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Protein Drugs Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Protein Drugs Market Size Market Share by Region in 2023
Figure 38. China Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Protein Drugs Market Size and Growth Rate (M USD)
Figure 44. South America Protein Drugs Market Size Market Share by Country in 2023
Figure 45. Brazil Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Protein Drugs Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Protein Drugs Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Protein Drugs Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Protein Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 56. Global Protein Drugs Market Share Forecast by Type (2025-2032)
Figure 57. Global Protein Drugs Market Share Forecast by Application (2025-2032)
